Medicare Mulls Coverage for New Alzheimer's Drug
Medicare launched a formal process that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer's drug whose high price tag and unproven benefits have prompted widespread controversy.
Landwebs
0
3
Medicare launched a formal process that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer's drug whose high price tag and unproven benefits have prompted widespread controversy.
